Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2017

Open Access 01-12-2017 | Commentary

Latin-American challenges and opportunities in rheumatology

Author: Francisco Airton Castro Rocha

Published in: Arthritis Research & Therapy | Issue 1/2017

Login to get access

Abstract

The importance of diseases to mankind is very similar worldwide. However, social and environmental issues, not to mention political and individual aspects, affect the prevalence and management of diseases and their outcomes. I present a brief and tentative comment to illustrate that the Latin-American rheumatology community, despite relevant gains in recent years, has some challenges to face in order to improve patient care in our region.
Literature
1.
Reveille JD, Muñoz R, Soriano E, Albanese M, Espada G, Lozada CJ, Montúfar RA, Neubarth F, Vasquez GM, Zummer M, Sheen R, Caballero-Uribe CV, Pineda C. Review of current workforce for rheumatology in the countries of the Americas 2012-2015. J Clin Rheumatol. 2016;22(8):405–10.CrossRefPubMed
2.
de Albuquerque CP. Inequality in the distribution of rheumatologists in Brazil: correlation with local of medical residency, Gross Domestic Product and Human Development Index. Rev Bras Reumatol. 2014;54(3):166–71.CrossRefPubMed
3.
Munoz-Louis R, Medrano-Sánchez J, Montufar R. Rheumatoid arthritis in Latin America: challenges and solutions to improve its diagnosis and treatment training for medical professionals. Clin Rheumatol. 2015;34 Suppl 1:S67–70.CrossRefPubMed
4.
da Mota LM, Brenol CV, Palominos P, Pinheiro Gda R. Rheumatoid arthritis in Latin America: the importance of an early diagnosis. Clin Rheumatol. 2015;34 Suppl 1:S29–44.CrossRefPubMed
5.
Ugarte-Gil MF, Silvestre AMR, Pons-Estel BA. Access to an optimal treatment. Current situation. Clin Rheumatol. 2015;34 Suppl 1:S59–66.CrossRefPubMed
6.
Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Bernardo WM. Pinheiro G da R, Sociedade Brasileira de Reumatologia. Guidelines for the drug treatment of rheumatoid arthritis. Rev Bras Reumatol. 2013;53:158–83.CrossRefPubMed
7.
Scheinberg M, Castañeda-Hernández G. Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice. Arthritis Res Ther. 2014;16(6):501.CrossRefPubMedPubMedCentral
8.
Castañeda-Hernández G, Szekanecz Z, Mysler E, Azevedo VF, Guzman R, Gutierrez M, Rodríguez W, Karateev D. Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies. Joint Bone Spine. 2014;81(6):471–7.CrossRefPubMed
9.
Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016;12(2):92–101.CrossRefPubMed
10.
Wahl ER, Yazdany J. Challenges and opportunities in using patient-reported outcomes in quality measurement in rheumatology. Rheum Dis Clin North Am. 2016;42(2):363–75.CrossRefPubMed
11.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.CrossRefPubMed
12.
von Feldt JM. The Evolution of the Pan-American League of Associations of Rheumatology. J Clin Rheumatol. 2016;22(3):107.CrossRef
13.
Pineda C, Muñoz-Louis R, Caballero-Uribe CV, Viasus D. Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems. Clin Rheumatol. 2016;35(10):2381–5.CrossRefPubMed
Metadata
Title
Latin-American challenges and opportunities in rheumatology
Author
Francisco Airton Castro Rocha
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2017
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-017-1247-7

Other articles of this Issue 1/2017

Arthritis Research & Therapy 1/2017 Go to the issue

Research article

Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus

Research article

VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes

Research article

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients

Research article

B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients

Research article

Role of endoplasmic reticulum stress in the protective effects of PPARβ/δ activation on endothelial dysfunction induced by plasma from patients with lupus

Research article

Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits